Implant Radiation Therapy Using Radioactive Iodine in Treating Patients With Localized Prostate Cancer (J-POPS)
Japanese Prostate Cancer Outcome Study by Permanent I-125 Seed Implantation [J-POPS]
Sponsor: Kurosawa Hospital
A observational or N/A phase clinical study on Prostate Cancer, this trial is completed. The trial is conducted by Kurosawa Hospital and has accumulated 13 data snapshots since 2005. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
13 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jul 2023 — Jul 2024 [monthly]
Completed
-
Jun 2022 — Jul 2023 [monthly]
Completed
Status: Active Not Recruiting → Completed
▶ Show 8 earlier versions
-
Jan 2021 — Jun 2022 [monthly]
Active Not Recruiting
-
Sep 2020 — Jan 2021 [monthly]
Active Not Recruiting
-
Jul 2020 — Sep 2020 [monthly]
Active Not Recruiting
-
Jul 2019 — Jul 2020 [monthly]
Active Not Recruiting
-
Jun 2018 — Jul 2019 [monthly]
Active Not Recruiting
-
May 2018 — Jun 2018 [monthly]
Active Not Recruiting
-
Apr 2018 — May 2018 [monthly]
Active Not Recruiting
Phase: NA → None
-
Jan 2017 — Apr 2018 [monthly]
Active Not Recruiting NA
First recorded
Jul 2005
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Kurosawa Hospital
- Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Fukui, Japan , Fukuoka, Japan , Gifu, Japan , Gunma, Japan , Hiragi, Japan , Isesaki, Japan , Izumo, Japan , Kanagawa, Japan , Kasama, Japan , Kobe, Japan and 15 more locations